VR and Scrip Training of PWA, Randomized Controlled Trial
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Dec 5, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying new ways to help people who have trouble speaking after a stroke, a condition called aphasia. The researchers want to find out if using a computerized script training program can improve the ability of Cantonese-speaking individuals to communicate verbally and also enhance their nonverbal thinking skills. Additionally, they are exploring whether virtual reality (VR) can make these improvements even better.
To participate in this trial, people need to be between 30 and 80 years old, have had a stroke more than six months ago, and be fluent in Cantonese. They should not have other serious brain conditions or significant speech issues. If eligible, participants will engage in training sessions that may involve both script training and VR experiences. It's important to note that the trial is not yet recruiting participants, and those who experience problems like nausea or headaches with VR will not be able to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. a stroke onset more than six months, with an Aphasia Quotient (AQ) below 96.4, as evaluated by the Cantonese version of Western Aphasia Battery (CAB; Yiu, 1992),
- • 2. premorbid fluent Cantonese speakers,
- • 3. aged between 30 and 80 years,
- • 4. no reported progressive neurogenic disorders such as dementia or Parkinson's disease,
- • 5. no motor speech disorders of moderate to severe level, and
- • 6. normal or corrected-to-normal vision and hearing functions
- Exclusion Criteria:
- • 1. concurrent participation in other aphasia treatment trials, and
- • 2. incompatibility with immersive VR exposure such as complains of nausea, headache, or other severe discomforts during trial use of a head-mounted device during screening.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Winsy WS Wong, PhD
Principal Investigator
Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported